Module 7

Don’t go solo – how to gather support

DATE: 11 March 2021 (16:00-18:00 GMT)

This course module will cover the following topics and provide participants with some additional further reading and information sources to look at, both before and after the session.

  • Bringing a team together, leading, and managing.
  • How do you form and manage the network of collaborations and partnerships you need?
  • Learn about accessing funding from grants or investors – what do they look for?
  • Map out the people and resources you need to take the next steps.

Mike Anstey, Cambridge Innovation Capital
Mike Anstey, Cambridge Innovation Capital, Partner

Dr Michael Anstey is a Partner specialising in life science investments. Before joining CIC he was a Principal in the Healthcare Practice Area at The BostonConsulting Group’s (BCG) Toronto office. Michael has experience in advising multinational businesses across North America, Europe, India, and Japan. Michael was also co-founder of an early-stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease.
Prior to BCG, Michael worked at Oxford Capital Partners, where he focused on investing in early-stage life science businesses. Michael earned his DPhil in Zoology in the field of neurobiology from the University of Oxford. Michael manages CIC’s investments in Bicycle Therapeutics (NASDAQ: BCYC), Congenica, Immutrin, PredictImmune, PolyProx Therapeutics, Sense Bio, StartCodon, and Storm Therapeutics.

Anya Roy, Illumina Accelerator, Head of Seed Investments and Technology UK/Europe

Anya is currently the Head of Seed Investments and Technology UK/Europe at Illumina Accelerator. She has experience as an Entrepreneur, venture capital Investor and as a Banker. She was previously the founder and CEO of Syrona, a digital health start-up that develops low-cost, non-invasive screening kits for women’s health issues pioneering a combination of digital and biological markers. She worked at Goldman Sachs and in life science venture capital at IP Group prior to founding her own company. She earned an MPhil with a focus in Bioscience from the University of Cambridge in Cambridge, England, and currently completing her Executive MBA from Saidbusiness school at Oxford University having been conferred the prestigious 30% Club Scholarship.

Dr Claire Button
Claire Button, CEO, Mentis Cura

Claire is Founder of Fusion Biomed, a specialist search, growth and investment partner for early-stage, high-growth life science and medtech companies. She founded Fusion Biomed to address challenges facing early-stage life science and medtech ventures as they grow from interesting technology or science into a fully formed company, through to exit. After her PhD in Immunopharmacology, Claire spent over 15 years working with entrepreneurs, stakeholders, and boards. She brings deep sector and commercial understanding, and a global network; partnering with ventures to build boards, secure investment, find commercial leaders, design business plans and other elements required for company success. Claire is CEO of Mentis Cura, a data-driven neuro-tech platform company,prognosing and diagnosing brain disorders for early intervention and accurate treatment. She is also a member of the medtech committee of Consilience Ventures, an investment fund investing in early-stage, high-growth ventures.